Press release
May 21, 2026
Iovance Biotherapeutics to Present at Upcoming Conference
Iovance Biotherapeutics, Inc. (IOVA)
SAN CARLOS, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced that Fred Vogt, PhD,